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It is well established that members of the protein kinase C (PKC) family seem to have
important roles in T cells. Focusing on the physiological and non-redundant PKC functions
established in primary mouse T cells via germline gene-targeting approaches, our current
knowledge deﬁnes two particularly critical PKC gene products, PKCθ and PKCα, as the
“ﬂavor of PKC” in T cells that appear to have a positive role in signaling pathways that are
necessary for full antigen receptor-mediated T cell activation ex vivo and T cell-mediated
immunity in vivo. Consistently, in spite of the current dogma that PKCθ inhibition might be
sufﬁcient to achieve complete immunosuppressive effects, more recent results have indi-
cated that the pharmacological inhibition of PKCθ, and additionally, at least PKCα, appears
to be needed to provide a successful approach for the prevention of allograft rejection and
treatment of autoimmune diseases.
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INTRODUCTION
Members of the protein kinase C (PKC) family belong to the ser-
ine/threonine protein kinase subfamily, which plays an important
role in the regulation of a variety of cell functions (Figure 2). The
PKC family was originally discovered by Nishizuka and colleagues
in 1977 (Takai et al., 1977) and consists of nine isotypes that are
expressed in a wide range of cell types and tissues (Figure 1). The
reasons for the heterogeneity of PKC isotypes are not yet fully
understood. T lymphocytes, for example, express up to eight dif-
ferent species of PKC isotypes (Table 1), which makes it difﬁcult
to determine the speciﬁc cellular functions of these individual
enzymes. The expression of more than a single PKC isotype in a
given cell could suggest functional redundancy and/or specializa-
tion. Table 1 summarizes the overall lymphoid expression patterns
and T cell phenotypes of knockout T cells and the different PKC
isotypes encoded in the human genome.
ROLE OF PKCθ IN IMMUNE CELL BIOLOGY
The main function of mature T cells is to recognize and respond
to foreign antigens. This process involves the activation, adhesion,
and differentiation of the resting cell into an effector lym-
phoblast that actively secretes immunoregulatory lymphokines or
displays targeted cytotoxicity, ultimately leading to the recruit-
ment of other cell types and initiation of an effective immune
response. T cell activation is triggered by the ability of the T
cell receptor (TCR) to recognize a peptide antigen, which is
bound to major histocompatibility complex class I (MHCI) or
class II (MHCII). T cells then begin to divide and differentiate
on the basis of the processed antigen. The effector cell CD4+
T helper cell subset (including TH1, TH2, and TH17 cells) per-
forms effector functions that are necessary to clear the pathogen.
TH1 CD4+ T cells produce IFN-γ and IL-2 and promote cell-
mediated immunity. TH2 CD4+ T cells produce IL-4, IL-5, IL-6,
IL-10, and IL-13 and lead to the activation of the humoral
immune system. TH17 CD4+ T cells produce IL-17, IL-21, and
IL-22 and play roles in the defense against extracellular bacteria
and fungi.
INVOLVEMENT OF PKCθ IN THE IMMUNOLOGICAL SYNAPSE
After cell–cell contact between a T cell and an APC, this con-
tact is stabilized during the initiation of an immune response
by interaction of the β2-integrin LFA-1 with its counterligand
ICAM-1 (Mazerolles et al., 1988; Dustin and Springer, 1989;
Penninger and Crabtree, 1999). LFA-1 avidity is controlled by
inside-out signaling via the control of integrin conformation and
surface distribution (Lub et al., 1995; Carman and Springer, 2003;
Dustin et al., 2004). One important inside-out signaling molecule
that controls cell adhesion is the small GTPase Rap1 (Kata-
giri et al., 2002; Shimonaka et al., 2003). Rap1A-deﬁcient T cells
show impaired LFA-1 clustering and adhesion after CD3 stim-
ulation (Duchniewicz et al., 2006). Letschka et al. (2008) found
a role of a PKCθ/RapGEF2 complex in regulating LFA-1 avid-
ity in T cells. These authors showed that after T cell activation,
PKCθ phosphorylates RapGEF2 at Ser960, which regulates Rap1
activation and LFA-1 adhesiveness to ICAM-1. In agreement,
this study showed that in OT-II TCR-transgenic CD4+ T cells,
LFA-1 clustering after antigen activation was impaired in PKCθ-
deﬁcient CD4+ T cells (Letschka et al., 2008). According to their
study, PKCθ seems to positively regulate the adhesive capacity of
T lymphocytes.
When a stable contact between a T cell and an APC is formed,
the T cell co-stimulatory receptor CD28 is activated by binding
to its cell ligands CD80 or CD86. Subsequently, the immuno-
logical synapse is generated at the contact area between the T
cell and the APC (Rao et al., 1999). Part of the immunological
synapse is the supramolecular activation complex (SMAC), which
is characterized by different signaling proteins, such as LCK (SRC
family tyrosine kinase), LFA-1 (lymphocyte function-associated
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FIGURE 1 |The human PKC gene family. PKC proteins are classiﬁed into
conventional PKCs (cPKC; α, β, and γ), novel PKCs (nPKC; ε, δ, θ, and η) and
atypical PKCs (aPKC; ζ and ι). cPKCs require Ca2+ and diacylglycerol (DAG)
for activation, nPKCs are Ca2+ independent and aPKCs require neither
Ca2+ nor DAG for activation.
antigen 1), and CD45 (Freiberg et al., 2002). Effective T cell stim-
ulation is characterized by the recruitment of PKCθ to the SMAC
(Schaefer et al., 2004), at which it is phosphorylated by LCK at
Tyr-90 (Liu et al., 2000). A physical interaction of PKCθ with the
cytoplasmatic tail of CD28 has been shown to be essential in this
recruitmentmechanism (Kong et al., 2011). Subsequently, PKCθ is
phosphorylated at different sites (Bauer et al., 2001; Bi et al., 2001;
Liu et al., 2002; Freeley et al., 2005; Lee et al., 2005) and autophos-
phorylated at Thr-219 (Thuille et al., 2005). Recently, Chuang et al.
(2011) identiﬁed the MAP4K3 GCK-like kinase (GLK) as a kinase
that directly phosphorylates PKCθ at Thr-538 which is essential
to activation of NF-κB in T cells. Phosphorylation is important
to retain PKCθ in the immunological synapse, in which one of its
functions seems to be the regulation of the immunological synapse
itself. Through the live imaging of components of the immuno-
logical synapse, the synapse has been shown to be dynamic
in wild-type mice but more stable in PKCθ-knockout mice,
which inﬂuences the strength, duration and location of signals
(Dustin, 2008).
RECRUITMENT AND ACTIVATION OF SIGNALING MOLECULES
Another important role of PKCθ is to recruit and activate sig-
naling molecules, such as phospholipase C (PLC), IL2-inducible
T cell kinase (ITK), TEC, phospholipase C γ 1 (PLCγ1), and SPAK
(a MAPKKK that ultimately activates AP1) to the immunolog-
ical synapse. PKCθ was identiﬁed to play a critical role in the
NF-κB and Ca2+/NFAT pathways to activate the IL-2 promoter.
Antigen binding to the TCR leads to an increase in intracel-
lular Ca2+, which activates calcineurin. Calcineurin dephos-
phorylates NFAT and leads to its nuclear import. Subsequently,
NFAT forms complexes with the AP-1 protein transcription fac-
tor family and regulates the expression of IL-2 by binding to
its promoter. PKCθ-knockout T cells were ﬁrst described by
FIGURE 2 | Involvement of individual PKC family members in different
aspects of T cell biology. Numerous studies identiﬁed PKC
isotype-selective functions in signaling pathways, necessary for full T cell
activation, differentiation and robust immune responses in vivo (for details
see text). The dashed line depicts PKC functions which were characterized
primarily via overexpression/knockdown studies in immortalized cell lines,
while a validation in a more physiological system is pending.
Sun et al. (2000). They generated PKCθ-knockout mice by replac-
ing the exon encoding the ATP-binding site of the kinase domain
with the neomycin resistance gene. In their study they found
strongly reduced proliferation of PKCθ−/− CD3+ T lympho-
cytes accompanied by a reduced secretion of IL-2. Suitably they
could show that TCR-initiated NF-κB activation was absent from
PKCθ−/− CD3+ T lymphocytes but was normal in thymo-
cytes indicating that PKCθ is essential for TCR-mediated T cell
activation (Sun et al., 2000).
Pfeifhofer et al. (2003) generated a conditional PKCθ-knockout
mouse by using Cre-mediated recombination where the complete
coding sequences of exons 3 and 4 are deleted, followed by a
frame shift mutation between exons 2 and 5. Additionally to the
results Sun et al. (2000) observed, they saw that a deﬁciency of
PKCθ abrogates NFAT transactivation after CD3/CD28 stimula-
tion. In addition, decreased intracellular Ca2+ ﬂux was observed
(Pfeifhofer et al., 2003).
To induce and maintain the complete IL-2-producing capac-
ity of a T cell after TCR stimulation and activation of CD28, the
RING (really interesting new gene)-type E3 ubiquitin ligase Cbl-b
must be inhibited. Cbl-b restricts activation of the TCR by inhibit-
ing the activation of PI3K (phosphoinositide-3-kinase; Fang and
Liu, 2001) and PLCγ1 (Heissmeyer et al., 2004; Jeon et al., 2004),
and it promotes the antigen-induced downregulation of the TCR
(Naramura et al., 2002). In response to the stimulation of CD28,
Cbl-b is ubiquitinylated and proteasomally degraded. Gruber et al.
(2009a) showed that PKCθ directly regulates the ubiquitinylation
and degradation of Cbl-b. After co-stimulation of the TCR and
CD28, Cbl-b was degraded in wild-type CD3+ T cells but not
PKCθ-deﬁcient CD3+ T cells, and the ubiquitinylation of Cbl-b
was strongly decreased after treatment with an inhibitor of PKCθ
(Gruber et al., 2009a).
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Table 1 | Lymphoid expression pattern and immune cell phenotypes of PKC isotype knockout mice.
Gene loci Tissue expression Knockout mouse immune phenotype Reference
Conventional PKCs
α Ubiquitous, high in T cells Reduced proliferation, reduced IFNγ production, defective IgG switching Pfeifhofer et al. (2006)
β Ubiquitous, high in B cells Neutrophil-, B-, mast cell defect Leitges et al. (1996),
Nechushtan et al. (2000)
γ Brain ND
Novel PKCs
δ Ubiquitous, high in T cells Enhanced IL-2 secretion, enhanced proliferation, proapoptotic Gruber et al. (2005),
Lutz-Nicoladoni et al. (2005)
ε Ubiquitous, high in T cells Macrophage defect, defective bacterial clearance, inﬂuence on the
nervous system
Castrillo et al. (2001),
Kumar et al. (2002)
η Ubiquitous, high in T cells Impairment of epithelial regeneration in wound healing, increased
susceptibility to tumor formation in skin carcinogenesis, defective
homeostatic proliferation
Chida et al. (2003),
Fu et al. (2011)
θ T cells, platelets, monocytes Reduced proliferation, reduced IL-2 production, abrogated AP-1, NF-κB,
and NFAT transactivation, impaired EAE development, impairedTH2
immunity against N. brasiliensis
Sun et al. (2000),
Pfeifhofer et al. (2003),
Marsland et al. (2004),
Salek-Ardakani et al. (2004, 2005)
Atypical PKCs
ζ Ubiquitous ImpairedTH2 cytokine secretion response Martin et al. (2005)
ι Ubiquitous Lethal phenotype
IN VIVO IMMUNE RESPONSES
During T cell development, thymocytes undergo a twofold
selection process. During positive selection, CD4+CD8+ double-
positive thymocytes bearing TCRs with low or moderate afﬁnity
to MHC/antigen complexes expressed on epithelial cells receive a
survival signal. During negative selection, the high-afﬁnity inter-
action of TCRs with self-MHC/self-peptide complexes selects the
thymocytes for apoptosis. Selected thymocytes downregulate CD4
or CD8 and leave the thymus as fully mature lymphocytes. To
address the question of whether PKCθ is involved in positive
selection, Morley et al. (2008) analyzed MHCII-restricted TCR-
transgenic and non-transgenic PKCθ-knockout mice. In both
mouse models, they found a severe defect in thymocyte positive
selection (Morley et al., 2008). In agreement with these results,
Gruber et al. (2010) also found a crucial role for PKCθ in the
positive selection of thymocytes in a pathway leading to the acti-
vation of ERK, NFAT, and NF-κB by analyzing MHCI-restricted
TCR-transgenic mice and non-transgenic PKCθ-knockout mice.
When a naive CD4+ T cell is activated, it differentiates into
the effector subsets TH1, TH2, or TH17. An imbalance of
this differentiation leads to autoimmunity and hypersensitivity.
Several studies showed that PKCθ is important in the regula-
tion of the TH2-mediated immune response (Marsland et al.,
2004; Salek-Ardakani et al., 2004, 2005; Tan et al., 2006). After
infection with Nippostrongylus brasiliensis, TH2 cell immune
responses were severely impaired in PKCθ−/− mice. Consis-
tent with these results, another in vivo study showed that PKCθ
appears to be involved in lung inﬂammation responses, which
are controlled by TH2 cells (Marsland et al., 2004; Salek-Ardakani
et al., 2004). PKCθ−/− mice develop drastically reduced pul-
monary hypersensitivity responses to inhaled allergens, such as
lung inﬂammation, eosinophil inﬁltration, and immunoglobulin
E production.
To address the question of whether PKCθ is involved in protec-
tion against bacterial infections, Sakowicz-Burkiewicz et al. (2008)
infected mice with Listeria monocytogenes (LM) and found that
PKCθ is responsible for normal LM-speciﬁc T cell responses. Fau-
connier et al. (2011) studied the role of PKCθ after the infection
of mice with Plasmodium falciparum. They found that PKCθ-
deﬁcient mice are resistant to the development of cerebral malaria,
and the recruitment and activation of CD8+ T cells in the brains of
the resistantmicewere reduced. To study the function of PKCθ in a
chronic persisting infection model, Nishanth et al. (2010) infected
mice with Toxoplasma gondii. PKCθ-deﬁcient mice suffered from
encephalitis and showed insufﬁcient parasite control. T. gondii-
speciﬁc CD4+ and CD8+ T cells were signiﬁcantly reduced in
the spleens and brains of infected PKCθ-deﬁcient mice, indi-
cating that PKCθ is important for intracerebral parasite control
(Nishanth et al., 2010).
Tan et al. (2006) and Salek-Ardakani et al. (2004, 2005) showed
that PKCθ is also important for full development of experimen-
tal autoimmune encephalomyelitis (EAE), a multiple sclerosis-like
autoimmune disease that is TH17 dependent. PKCθ−/− mice
failed to develop EAE after injection with myelin oligodendrocyte
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glycoprotein (MOG). In addition, TH17 cells produced less IL-17
and failed to inﬁltrate the CNS.
Recently, Kwon et al. (2012) showed that PKCθ−/− mice had
lower levels of Stat3, a transcription factor required for TH17 dif-
ferentiation, whereas the activation of Stat4 and Stat6, which are
important for TH1 and TH2 differentiation was normal. Using a
luciferase reporter gene driven by the Stat3 promoter they showed
that PKCθ stimulates Stat3 transcription via the NF-κB and AP-
1 pathway, resulting in the stimulation of TH17 differentiation
(Kwon et al., 2012).
In striking contrast, PKCθ−/− mice showed normal TH1
responses after infection with Leishmania major (Marsland et al.,
2004), suggesting a lineage-speciﬁc function of PKCθ.
Garaude et al. (2008) found an impaired anti-leukemic
response in PKCθ-deﬁcient mice. These authors induced leukemia
with Moloney-murine leukemia virus and found a higher disease
incidence and a more rapid disease onset in PKCθ-knockout mice.
Additionally, the intravenous injectionof EL4 cells induced tumors
earlier in PKCθ−/− mice.
To avoid an uncontrolled immune response, the maintenance
of the balance between immune tolerance to self-antigens and anti-
tumor responses and the regulation of the suppression of effector
T cells is mediated by regulatory T cells (Treg cells; Sakaguchi
et al., 2008). Treg cells are produced in the thymus (nTreg) or from
naive effector T cells (iTreg), and both types of Treg cells express
the transcription factor FoxP3, whereas nTreg cells also express
Helios (Zheng and Rudensky, 2007; Thornton et al., 2010). Treg
cells are able to suppress the function of CD4+ and CD8+ T cells,
dendritic cells (DCs), NK cells, and B cells (Gupta et al., 2008b;
Shevach, 2009). A deﬁciency of Treg cells leads to multi-organ
inﬂammatory diseases inmice (Sakaguchi et al., 2008). Gupta et al.
(2008a) found a strongly reduced number of Treg cells in PKCθ-
knockoutmice, but these cells were as potent as wild-type Treg cells
in inhibiting effector T cell activation, indicating that PKCθ was
not required for Treg cell-mediated inhibitory functions. However,
Zanin-Zhorov et al. (2011) found that PKCθwas sequestered away
from the Treg immunological synapse with confocal imaging, and
using a colitismousemodel and apoorly describedPKCθ inhibitor,
they postulated a PKCθ-mediated negative feedback loop that
enhances the activity of human Treg cells. A very recent publica-
tion by Ma et al. (2012) suggested that the differentiation of iTreg
cells is inhibited by PKCθ-mediated signals via the AKT-Foxo1/3A
pathway.
ROLE OF OTHER PKCs IN IMMUNE CELL BIOLOGY
PKCδ
PKCδ is an isozyme belonging to a novel subclass of the ser-
ine/threonine PKC family and is expressed in most tissue and
cell types. The kinase catalytic activity of PKCδ is mainly affected
by trans- and autophosphorylation at conserved Ser/Thr sites in
the catalytic domain (activation loop, turn motif, and hydropho-
bic motif), by tyrosine phosphorylation (by Src family kinases
in the context of oxidative stress and DNA damage; Lu et al.,
2007; Lomonaco et al., 2008) and by caspase-mediated proteolysis
(during apoptosis; Kikkawa et al., 2002). Generally, upon stimu-
lation, PKCδ translocates from the cytosol or nucleus to mem-
brane/cytoskeletal compartments, enabling the phosphorylation
of many target proteins and leading to the activation of sev-
eral signal transduction pathways. It has also been shown that
PKCδ can shuttle to mitochondria (Li et al., 1999; Majumder
et al., 2001). PKCδ negatively affects a wide variety of cellu-
lar functions by inhibiting cellular growth and proliferation and
promoting cell death, but it has also been shown to contribute
to mitogenesis (Watanabe et al., 1992; Nakagawa et al., 2005;
Santiago-Walker et al., 2005), migration (Jackson et al., 2005),
differentiation (Cerda et al., 2001; Yang et al., 2006; Zhang et al.,
2008), and tumor progression. Different studies have revealed a
role for PKCδ in the initiation, progression, and maintenance of
inﬂammatory processes by affecting NF-κB transactivation (Satoh
et al., 2004; Hsieh et al., 2007).
Additionally, a pro-apoptotic role for PKCδ has been described
in T cells. The subcellular localization of PKCδ in human T cells
during apoptotic induction by cytokine deprivation and Fas lig-
ation and during the prevention of apoptosis by IFNβ addition
was analyzed by Scheel-Toellner et al. (1999). The addition of
INFβ to T cells in a pro-apoptotic environment led to a rapid re-
translocation of PKCδ from the nucleus and inhibited the caspase-
3-mediated proteolytic activation of PKCδ (Scheel-Toellner et al.,
1999). An essential role for PKCδ in the apoptotic induction of
mouse thymocytes was addressed in a study by Lutz-Nicoladoni
et al. (2005). Thymocytes from a large panel of PKC-knockout
mice were forced to undergo apoptosis in vitro via treatment
with different apoptotic inducers (PDBu, dexamethasone, FasL,
staurosporine, or etoposide), and the selective involvement of
PKC isotypes in this process was assessed. PKCδ-deﬁcient pri-
mary mouse double-positive thymocytes were protected from
apoptotic induction, indicating a clear pro-apoptotic role of
PKCδ (Lutz-Nicoladoni et al., 2005). Gruber et al. (2005) inves-
tigated the proliferative response and IL-2 cytokine secretion of
PKCδ-deﬁcient CD3+ T cells versus control cells in vitro via allo-
genic MHC stimulation and in vivo via injection of anti-CD3
antibodies. The signiﬁcantly enhanced proliferation and IL-2
cytokine production of mature T cells and the increased blood
plasma IL-2 levels in PKCδ-null mice led to the assumption that
PKCδ acts as a negative regulator of T cell activation responses
(Gruber et al., 2005).
An involvement of PKCδ in lytic granule exocytosis of CD8-
CTLs (cytotoxic T lymphocytes) was shown by Ma et al. (2007,
2008). The combined use of pharmacological inhibitors and mice
with targeted gene deletions allowed these authors to demonstrate
that PKCδ is selectively required for lytic granule movement in
response to TCR engagement on CD8+ CTLs but is dispens-
able for activation, cytokine production, and the expression of
cytolytic molecules in response to TCR stimulation. In a follow-
up study, the authors showed via a time-lapse analysis of living
CD8+ CTLs that PKCδ localizes to secretory lysosomes and
accumulates at the immunological synapse during target killing
(Ma et al., 2007, 2008).
A correlation between impaired PKCδ activation/ phosphoryla-
tion and the development of idiopathic and hydralazine-induced
lupus was postulated by Gorelik et al. (2007). PMA-stimulated
CD4+ T cells from patients with lupus showed an impaired PKCδ
activity state compared with CD4+ T cells from healthy donors.
This defect was responsible for decreased ERK signaling and led
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to increased CD70 expression due to insufﬁcient demethylation of
the CD70 promoter (Gorelik et al., 2007).
The expression level and activity state of PKCδ and PKCζ was
investigated in amyloid β1–42 (Aβ1–42)-reactive T cell popula-
tions in Alzheimer disease (AD) patients in comparison to healthy
individuals. This study clearly showed the increased expression
and activation of PKCδ in Aβ-stimulated peripheral T cells from
early AD patients, whereas the same treatment induced two dis-
tinct (p)PKCδ and (p)PKCζ T cell subpopulations in severe AD
patients (Miscia et al., 2009).
PKCε
PKCε was ﬁrst discovered among the novel PKC isotypes and
is expressed at high levels in neuronal, hormonal, and immune
cells. Essential roles for PKCε have been established in numerous
cellular functions, including proliferation, differentiation, gene
expression, muscle contraction, transport, tumorigenesis, exocy-
tosis, and endocytosis. In addition to the classical activation by
auto- and trans-phosphorylation at conserved sites in the catalytic
domain, PKCε is activated by several different second messen-
gers, including diacylglycerol (DAG), phosphatidylinositol-3,4,5-
triphosphate, and fatty acids. PKCε is targeted to speciﬁc cellular
compartments depending on the interaction of secondmessengers
with its C1 domain (DAG and tridecanoic acids evoke a plasma
membrane and/or cytoskeleton translocation, whereas arachi-
donic and linoleic acids lead to recruitment to Golgi networks)
and via crosstalk with adaptor proteins (i.e., Rack1 and β-Cop).
An associationof PKCε (via its actin-bindingmotif)with actinﬁla-
ments in response to phosphatidylserine-independent stimulation
has been reported (Akita, 2002).
In T cells, numerous studies have directly shown a positive
role of PKCε in the regulation of NF-κB/NFAT/AP1 pathways
leading to IL-2 upregulation; the activation-dependent transloca-
tion of PKCε from the cytosol to the membrane compartment in
TCR/CD3- or PMA-stimulated human PBLs has been reported
previously (Keenan et al., 1997). The neutralization of PKCε
in this cell type via the introduction of antagonistic antibod-
ies led to a downregulation of IL-2 synthesis (Szamel et al.,
1998). Jurkat T cells expressing a constitutively active PKCε
mutant showed increased AP1 and NFAT1 transactivation (Genot
et al., 1995). An inhibitory effect of eicosapentaenoic acid (EPA)
and docosahexaenoic acid (DHA) in the plasma membrane
translocation of PKCε (and PKCα), NF-κB nuclear transloca-
tion, and IL-2 transcription in PMA-stimulated Jurkat T cells has
been described (Denis et al., 2005). A pivotal role for PKCε in
thrombin-mediated ERK1/2 activation in Jurkat cells has been
shown by Maulon et al. (2001). The poor ability of neonatal
T cells to produce lymphokines was linked to a lower PKCε
(and PKCβ, PKCθ, and PKCζ) expression level in this cell type,
which is correlated with an activation defect of MAPK pathways
(Hii et al., 2003).
Interestingly, Gruber et al. (2005) reported that mice carrying
a homozygous disruption of the PKCε locus showed unaltered
T cell development and maturation; in addition, mature primary
CD3+ T cells isolated from PKCε−/− mice showed normal pro-
liferation, IL-2 secretion responses, and NF-κB transactivation
upon CD3/CD28 stimulation or allogeneic MHC presentation,
suggesting that PKCε loss of function is compensated for by
other members of the PKC family. In contrast to the described
redundant function of PKCε in mouse T cell proliferation, a
role of the PKCε isotype in the regulation of human CD4+
T cell proliferation and sensitivity to TGFβ1 has been shown
by Mirandola et al. (2011). PKCε silencing by siRNA led to
decreased IL-2 receptor chain expression and proliferation and
reduced NF-κB1 and NF-κB2 gene expression upon CD3/CD28
stimulation, whereas the inhibitory effects of TGFβ1 were poten-
tiated by PKCε downregulation. In addition, a possible con-
nection between increased PKCε expression levels in CD4+
T cells from Hashimoto thyroiditis patients and the molecu-
lar pathophysiology of this autoimmune disease was postulated
(Mirandola et al., 2011).
Some studies have identiﬁed an anti-apoptotic role for PKCε:
Jurkat T cells were rescued from Fas-mediated apoptosis by
PKCε via the p90Rsk-dependent phosphorylation and inactiva-
tion of BAD (Bertolotto et al., 2000). The basis for the deletion
of autoreactive thymocytes during negative selection was previ-
ously addressed (Simon et al., 2000); a lack of the constitutive
expression of PKCε in antigen-stimulated CD4+/CD8+ thymo-
cytes (in comparison to mature T cells) leading to an inhibition
of NF-κB activity and increased cell death was postulated as a
probable cause.
A positive involvement of PKCε in the recovery of downreg-
ulated sphingosine-1-phosphate receptor 1 (S1PR1) in primary
mouse CD4+ T cells was investigated (Graeler et al., 2003) in
PKCε-null mice and with PKCε-selective inhibitors.
Quann et al. (2011) established a new redundant role for PKCε
and PKCη in T cell polarity; the photoactivation of TCR induced
a rapid accumulation of both PKC isotypes in a broader domain
of the plasma membrane, in which they were required to pro-
mote the recruitment of PKCθ to the center of the immunological
synapse and subsequent microtubule-organizing center (MTOC)
reorientation.
PKCζ
PKCζ is a calcium- and diacylglycerol-independent serine/
threonine protein kinase that belongs to the atypical subfam-
ily of PKC isoforms and displays strong homology (more than
70%) to PKCι/λ. It is ubiquitously expressed but is more highly
expressed in the lung, brain, and testis. PKCζ contains a PB1
domain in the N-terminus that recognizes OPCA (OPR/PC/AID)
motifs of other proteins, such as the scaffold proteins PAR-6 and
ZIP/p62 and the kinase MEK5. PKCζ activity is regulated by PDK-
1 transphosphorylation of the catalytic domain activation loop,
autophosphorylation, and important lipid components, such as
phosphatidylinositols, phosphatidic acid, arachidonic acid, PIP3,
and ceramide. Prostate apoptosis response-4 (Par-4) and parti-
tioning defective gene-3 (PAR-3) have been reported to inhibit
PKCζ activity through a speciﬁc protein–protein interaction. PKCζ
has been shown to be involved in the regulation of several criti-
cal pathways for cell survival, proliferation, differentiation, and
cell polarity, thereby affecting the NF-κB and MAPK pathways.
A special role in modulating translation via the p70S6 kinase
signaling cascade has also been described by numerous studies
(Hirai and Chida, 2003). Recently, a link between PKCζ activity
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and TGFβ receptor trafﬁcking and degradation has been shown
(Gunaratne et al., 2012).
The activation of the PKCζ isotype has been shown to be
an important step in the IL-2-mediated proliferation of T cells
and in maintaining the integrity of the actin cytoskeletal struc-
ture (Gomez et al., 1995). Furthermore, an association between
PKCζ and PI3K has been reported to be necessary for the phos-
phorylation/activation of PI3K in IL-2-stimulated TS1-α/βmouse
T cells (Gomez et al., 1996). Through the transient overex-
pression of wild-type or a dominant-negative mutant of PKCζ
in Jurkat T cells, a previous study (San-Antonio et al., 2002)
observed that PKCζ can phosphorylate NFAT and regulate its
activation status. Additionally, an involvement of both PKCζ
and PI3K in NF-κB/c-Rel transactivation regulation in TNFα-
stimulated Jurkat T cells was postulated (Martin et al., 2001). A
previous study (Sanchez-Valdepenas et al., 2007) addressed the
effect of TCR/CD28 co-stimulation on the inducible phosphory-
lation/transactivation of the NF-κB members p65/RelA and c-Rel.
Cot kinase, PKCζ , and NF-κB-inducible kinase (NIK) seemed to
be involved in potentiating c-Rel transactivation activity through
the phosphorylationof a restricted set of Ser residues,whereasNIK
seemed to be unnecessary for the activation of p65. Additionally,
Gruber et al. (2008) found a physical and functional interaction
between PKCζ and the novel PKCθ isotype in the NF-κB activation
of Jurkat T cells. A stimulation-dependent colocalization of the
PKCζ /ι–PKCθ complex to lipid rafts was monitored via confocal
microscopy. However, peripheral CD3+ T cells isolated from the
spleen and lymph nodes of PKCζ-deﬁcient mice showed normal
proliferation and IL-2 cytokine responses to CD3/CD28 activa-
tion, indicating a possible functional redundancy with PKCι/λ,
the closest structural relative (Gruber et al., 2008).
A critical role for PKCζ in IL-4 signaling and TH2 differentia-
tion in vitro and in vivo has been reported (Martin et al., 2005).
PKCζ-deﬁcient CD4+ T cells showed an impaired secretion of TH2
cytokines and a defective Stat6/Jak1 pathway. Moreover, PKCζ−/−
mice were protected from ovalbumin-induced TH2-driven allergic
airway disease in an asthma model.
A protective role for PKCζ against FasL-induced apoptosis
was previously described (Leroy et al., 2005); PKCζ interfered
with FADD recruitment to the death-inducing signaling complex
(DISC) and subsequent caspase-8 processing.
PKCζ has been shown to act in combination with nitric oxide
synthase (NOS) in the regulation of thyroid hormone (TH)-
mediated T cell proliferation (Barreiro Arcos et al., 2006); TH
treatment increased atypical PKCζ expression and NOS activity,
whereas PKCζ inhibition abrogated the basal and TH-induced
activation of NOS.
A role for PKCζ in the biological processes of adhesion and
cell motility has been described by several studies. The mecha-
nismof theCD4-triggered regulation of LFA-1-mediated adhesion
was investigated (Trucy et al., 2006). CD4 binding increased the
activity of both PDK1 and PKCζ, and both kinases were neces-
sary for the downregulation of LFA-1-dependent adhesion in the
A201-CD4+ T cell line in a PI3K-dependent manner. Real et al.
(2007) showed that PKCζ and PKCι were both required for T cell
motility and the ability to scan DCs downstream of chemokine
receptors.
PKCη
PKCη is classiﬁed into the novel PKC subfamily and shows a high
sequence similarity toPKCε. Itwas originally isolated fromacDNA
library of mouse skin in 1990 (Osada et al., 1990) and is localized
on human chromosome 14 (Quan and Fisher, 1999) and mouse
chromosome 12 (Chida et al., 1998). It is predominantly expressed
in squamous epithelia including skin, tongue, esophagus, and tra-
chea (Koizumi et al., 1993), but at high levels also in T and B
cells (Mischak et al., 1991). In addition to phosphatidylserine and
diacylglycerol, PKCη can be speciﬁcally activated by cholesterol
sulfate (Ikuta et al., 1994). An involvement in keratinocyte cell
growth, terminal differentiation, and cell cycle arrest has been
reported by several studies: PKCη was shown to associate with
and to activate Fyn, leading to keratinocyte growth arrest and
differentiation (Cabodi et al., 2000); a PKCη induced terminal
differentiation through a transcriptional activation of TGas1 and
involucrin was described by Ueda et al. (1996) and Eﬁmova and
Eckert (2000). In addition, PKCη has been shown to induce G1
arrest in keratinocytes via an inhibition of cyclin-dependent kinase
2 activity (Kashiwagi et al., 2000). An important role in the regula-
tion of cell division and cell death during early B cell development
was postulated by the work from Morrow et al. (1999).
The different lipid raft localization pattern of PKCα, PKCη,
and PKCθ in cisplatin-induced apoptotic Jurkat T cells was
investigated by Solstad et al. (2010). A selective upregulation
of PKCα in these microdomains upon apoptosis induction was
revealed, whereas the levels of PKCη and PKCθ were signiﬁcantly
reduced.
Recently, Fu et al. (2011) found a pivotal role of PKCη in T cell
activation and homeostatic proliferation. Comparing the pheno-
types of PKCη−/−, PKCθ−/−, andmicewith a targeted disruption
of both PKC isoforms, they were able to show that both iso-
forms share some redundancy in T cell biology. Both isoforms are
recruited to the immunological synapse upon TCR stimulation
and double-knockout mice showed a more severe defect in pos-
itive selection. Additionally, they found speciﬁc non-redundant
functions as in self-antigen-dependent homeostatic proliferation.
Using a live imaging approach a TCR-induced recruitment of GFP
fusion proteins of PKCη and PKCε to the plasma membrane was
also described by Quann et al. (2011). The timely well coordinated
localized enrichment of these two isoforms served as a prerequi-
site for the subsequent translocation of PKCθ to the center of
the immunological synapse, necessary for the regulation of T cell
polarity and T cell effector functions.
PKCβ
The alternative splicing forms PKCβI and PKCβII are members of
the calcium-activated, phospholipid- and DAG-dependent classi-
cal or conventional PKC subfamily. Numerous studies have shown
their role in various cellular processes, such as the regulation of
B cell development and activation/proliferation, oxidative stress-
induced apoptosis, androgen receptor-dependent transcription
regulation, insulin signaling, and endothelial cell proliferation.
In B cells, a signaling link between PKCβ and BTK has been
described; PKCβ can downregulate BTK function through the
direct phosphorylationof BTKat Ser-180, inhibiting itsmembrane
translocation and subsequent activation (Kang et al., 2001). A key
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role for PKCβ in BCR-induced NF-κB activation has been shown
(Sommer et al., 2005); the direct phosphorylation of CARMA1 at
three serines within its linker region induced its translocation into
lipid rafts, the recruitment of BCL10/Malt1 and the subsequent
activation of signaling molecules downstream of the CBM com-
plex. Furthermore, PKCβ seems to play an important, even dual
role in insulin signaling pathways: in muscle cells, PKCβ mediates
insulin-dependent DNA synthesis through the RAF1-MAPK/ERK
signaling cascade downstream of insulin receptor substrate 1
(IRS1), and in adipocytes, it negatively regulates glucose trans-
port by inhibiting the translocation of the glucose transporters
GLUT1 and GLUT4 (Formisano et al., 2000; Bosch et al., 2003;
Perrini et al., 2004).
A selective impact of PKCβ on T cell migration has been shown
by several studies (Volkov et al., 1998, 2001). LFA-1-triggered T cell
locomotion led to the speciﬁc recruitment of PKCβ and PKCδ to
the MTOC and microtubules. A PKCβ-deﬁcient T cell line was
unable to either crawl or develop a polarized microtubule array
upon integrin cross-linking,whereas the ability to adhere and form
actin-based pseudopodia remained unaffected. The reconstitution
of PKCβ(I) in non-motile PKCβ-deﬁcient T cells restored their
locomotory behavior in response to an LFA-1 signal.
The possible involvement of PKCβ in IL-2 gene transcription
and/or IL-2 protein secretion upon TCR/CD28-induced T cell
activation has been addressed by several studies (Long et al., 2001;
Dreikhausen et al., 2003). The downregulation of PKCβ synthe-
sis in Jurkat T cells via the addition of antisense oligos resulted
in the suppression of the activation of MAPK/NF-κB/NFAT path-
ways and a complete inhibition of IL-2 transcription and secretion.
However, a study performed with a PKCβ-deﬁcient HUT78 T cell
clone excluded a possible role for IL-2 transcription and transla-
tion but demonstrated an involvement of PKCβ in IL-2 exocytosis.
Thuille et al. (2004) investigated the physiological role of PKCβ in
primary mouse T cells employing a PKCβ-deﬁcient knockout line
and found mostly normal activation-induced proliferation and
IL-2 secretion responses. However, it is conceivable that other
members of the cPKC family, such PKCα, could compensate for
the lack of this redundant PKC isotype in T cells.
In 2010 a re-investigation of IL-2 expression in PKCβ silenced
Jurkat T cells via antisense RNA technology revealed a stimula-
tion dependent decreased IL-2 production, whereas the CD25
expression was signiﬁcantly increased. In addition, PKCβ loss
of function affected also CD69 surface levels and IL-8 produc-
tion (Cervino et al., 2010). In the same year a scientiﬁc group
investigated the inﬂuence of PKCβ on PMA induced apoptosis
protection in Jurkat T cells and HL-60 human leukemia cells. The
downregulation of PKCβ via shRNA or the speciﬁc small inhibitor
enzastaurin reversed PMA induced protection of cell death
(Meng et al., 2010).
PKCα
Additional to PKCθ also PKCα, a member of the conventional
PKCs plays an important role in the induction of a robust
immune response. By transfecting fetal thymuses with consti-
tutively active and dominant-negative forms of PKCα, Michie
et al. (2001) showed that this isoform plays a speciﬁc role
in the differentiation and expansion of immature thymocytes.
Iwamoto et al. (1992) established a transgenic mouse line carrying
rabbit PKCα cDNA under the control of the regulatory element
of human CD2. In response to stimulation with anti-CD3, they
found that the transgenic thymocytes proliferated extensively and
produced IL-2 (Iwamoto et al., 1992). Lallena et al. (1999) and
Trushin et al. (2003) showed that PKCα regulates IκB kinase and
NF-κB in T cells.
PKCα was shown to be involved in the activation of the
PI3K/Akt pathway, which is involved in T cell development, sur-
vival, and migration (Jones et al., 2000; Haxhinasto et al., 2008;
Sauer et al., 2008). Using PKC inhibitors and in vitro kinase assays
with recombinant inactive Akt as a substrate, Yang et al. (2006)
showed that PKCα could phosphorylate Akt at Ser473 dependent
on TCR activation. These authors also performed knockdown
analysis in Jurkat T cells and found decreased TCR-induced phos-
phorylation of Akt at Ser473. PKCα and PKCθ are both involved
in TCR downregulation (von Essen et al., 2006). von Essen et al.
(2006) investigated the role of PKC isotypes in TCR downregula-
tion and found an important role for PKCα in TCR comodulation
(downregulation of non-engaged TCRs). Moreover, PKCα seemed
to be responsible for the induction of endocytosis of non-engaged
TCRs that recycle to the contact zone between the T cell and the
APC. PKCθ, however, seemed to be responsible for inducing the
endocytosis of directly triggered TCRs at the contact zone. Fur-
thermore, a study showed the involvement of PKCα in allergic
processes (Oh et al., 2004).
Our laboratory identiﬁed PKCα as a physiological and non-
redundant PKC isotype in signaling pathways that are necessary
for T cell-dependent IFNγ production and IgG2a/2b antibody
responses using PKCα-knockout mice (Pfeifhofer et al., 2006).
PKC LMWI (LOW-MOLECULAR-WEIGHT INHIBITOR)
IN THE CLINIC
Studies have shown that PKCθ−/− mice fail to develop exper-
imental allergic encephalomyelitis (EAE) and display drastically
reduced lung inﬂammation after the induction of allergic asthma
and alloreactivity in TX medicine, suggesting that PKCθ by itself is
an attractive monotarget for modulation of the immune response.
While this published evidence validates PKCθ inhibition being
essential, more recent results have indicated that additional PKC
isotypes are involved in critical T cell signaling pathways. Because
PKCθ and PKCα are both highly expressed in T cells (GNF SymAt-
las (http://symatlas.gnf.org/SymAtlas) and have isotype-selective
functions in T cells (Sun et al., 2000; Pfeifhofer et al., 2003, 2006),
whether PKCθ and PKCα also exert overlapping functions has also
been investigated. Gruber et al. (2009b) generated PKCα−/−θ−/−
double-knockout mice and found that the NFAT pathway plays a
predominant role in the collaborative action of PKCθ and PKCα.
The NFAT kinase GSK3β was hyper-reactive in PKCα−/−θ−/−
double-knockoutCD3+ Tcells. Subsequently, these authors found
reduced nuclear translocation and DNA binding of NFAT. In
in vivo studies, PKCα−/−θ−/− double-knockout T cells showed
strongly reduced IL-2 cytokine secretion after injection of an
anti-CD3 monoclonal antibody. Additionally, the mice showed
an impaired alloimmune response, leading to signiﬁcantly pro-
longed allograft survival in heart transplantation experiments
(Gruber et al., 2009b).
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To obtain complete immunosuppressive effects, the inhibition
of more than PKCθ appears to be needed, and the pharmaco-
logic inhibition of multiple PKC isotypes may provide a successful
approach to avert T cell effector functions that are relevant for
diseases such as psoriasis, atopic dermatitis, and allergies, as
well as other indications, including asthma, rheumatoid arthritis,
multiple sclerosis, and transplant rejections.
Sotrastaurin (AEB071) is an immunosuppressive drug that
inhibits multiple classical and novel members of the PKC fam-
ily, resulting in decreased T lymphocyte activation (Evenou et al.,
2009). In primary human and mouse T cells, AEB071 abrogated
IL-2 secretion and CD25 expression, which are markers of early
T cell activation. CD3/CD28-induced T cell proliferation, and
LFA-1-mediated T cell adhesion were potently inhibited, and
unlike previous PKC inhibitors, the apoptosis of murine T cell
blasts was not enhanced (Evenou et al., 2009). These mechanistic
studies on NF-κB and NFAT transcription factor transactivation
additionally suggest that AEB071 and CsA have a complementary
effect, resulting in the combined inhibitionof IL-2 secretion. Addi-
tionally, other results suggest that AEB071 but not CsA inhibits the
adhesive capacities of T lymphocytes.
Skvara et al. (2008) performed a clinical study with patients
suffering from psoriasis in which the patients received sin-
gle and multiple oral doses of AEB071. They found a strong
reduction in the clinical severity of psoriasis and a histolog-
ical improvement in skin lesions, indicating that sotrastaurin
may provide a new therapeutic option for psoriasis (Skvara
et al., 2008). Even so, we cannot exclude additional PKC iso-
types being involved in critical T cell signaling pathways. The
effect of AEB071 on PKCθ, including other classical and novel
PKC family members expressed in T cells, is the likely mech-
anism responsible for the strong AEB071 immunosuppressive
activity.
NEW CANDIDATE EFFECTOR PATHWAYS MEDIATED
BY PKC IN T CELLS
The challenge ahead for immunologists is the further eluci-
dation of the molecular and cellular processes of PKCα and
PKCθ that govern the development and function of T cells.
PKC-mediated signaling in NFAT/AP-1 transactivation critically
involves a pathway of the orphan nuclear receptor NR2F6. There is
evidence that PKC-induced signaling involvesNR2F6 inactivation,
presumably by stimulating the release of NR2F6 from DNA-
binding sites. This inactivation facilitates NFAT/AP-1 binding
to its enhancers in the IL-2 and IL-17A promoters. In agree-
ment, PKCα−/−/θ−/− double-knockout T cells show almost no
TCR/NFAT/AP-1 transactivation signaling (Gruber et al., 2009b),
whereas NR2F6-knockout T cells show markedly upregulated
TCR/NFAT/AP-1 transactivation (Hermann-Kleiter et al., 2008).
However, PKCα and PKCθ might have an even broader role in
regulating T cell functions than just acting downstream of T cell
antigen receptors. Thus, despite the signiﬁcant progress in assem-
bling the PKC puzzle in T lymphocytes, deﬁning downstream
PKC substrates, including their effector functions, triggered by
this phosphorylation step remains to be investigated in physio-
logical settings. From these investigations, innovative possibilities
are likely to emerge for the manipulation of T cell path-
ways in treating immunological diseases by suppressing patho-
physiological immune responses or augmenting host-protective
immunity.
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